Key takeaways
- Understand that milia and syringomas come from different tissue
- Learn what to look at first when you're trying to tell them apart
- See why recurrence follows one of them and not the other
- Take a checklist of questions into your consultation
You lean in close to the mirror, look under your eyes, and find several small grains that makeup won't cover. They're neither hard nor soft to the touch, and squeezing does nothing.
You assume it's acne and wait a few days, and when nothing changes you start searching. Then one page says milia and another says syringoma, and you're stuck before you've even worked out which explanation applies to you.
This article separates the two conditions first, then walks through the order in which to check and manage them.
This article summarizes treatment information from BeautyStone Clinic in Hongdae, Seoul. Individual results vary, so please decide with a board-certified dermatologist whether a given procedure suits you.
The frustration of squeezing and getting nothing
The frustration of squeezing and getting nothing
Acne gives you something when you press it. These grains under the eye don't respond no matter how hard you push, so your hand keeps going back and all you end up with is a red eye area.
There's a good chance it's one of two things, and they behave quite differently. A New Zealand dermatology resource describes a milium as a small cyst containing keratin*, usually appearing in multiples and particularly prominent on the eyelids and cheeks. What's inside is a plug of keratin, so unless the surface is opened there's no route out.
keratin: the protein that makes up the surface layer of the skin
A syringoma is different. Nothing is trapped inside it. The tissue itself has grown. That's why two bumps that look similar in the same spot can call for completely different handling.
So when squeezing doesn't work, it isn't that your technique is wrong. Some of what appears there simply isn't built to be squeezed out. The first step is to work out which one you're looking at, not to press harder.
The frustration of squeezing and getting nothing
How milia and syringomas differ to the eye
How milia and syringomas differ to the eye
Both surface as small bumps around the eye, but they start in different tissue and settle at different depths. That difference decides almost everything about how they're managed.
| Item | Milia | Syringoma |
|---|---|---|
| Where it starts | A small cyst holding keratin | A benign tumour from a sweat duct |
| Color and feel | Closer to white, firm | Skin colored or yellowish |
| Depth | Sits nearer the surface | Extends into the dermis |
| Course | Can clear on its own | Doesn't disappear by itself |
The same resource notes that milia are common in all ages and both sexes, and may clear in a few weeks or persist for months or longer. Where treatment is warranted, it describes de-roofing the lesion with a sterile needle or blade and lifting the contents out.
For syringomas it explains that they're a benign adnexal tumour derived from the acrosyringium, commonly found in clusters on and around the eyelids. They measure one to three millimetres across, affect roughly one percent of the population, and usually appear during or after adolescence. Being benign, their significance is mainly cosmetic.
Recurrence is where the two accounts diverge. The same resource notes that syringomas can come back after superficial treatment because they penetrate the deep dermis. A research paper gives the same reason, reporting that the bulk of the abnormal tissue can extend as far down as the upper reticular dermis, making these tumours resistant to superficial surgical destruction.
That's why you'll read one review saying it was over in a single visit and another saying it keeps coming back after several. There's a fair chance those two people weren't dealing with the same thing.
Why BeautyStone Clinic separates the two before anything else
Why BeautyStone Clinic separates the two before anything else
At BeautyStone Clinic we suggest identifying which type you have before choosing a method. Picking an approach while the diagnosis is still open is how expectations and outcomes end up out of step.
Why BeautyStone Clinic separates the two before anything else
In the consultation we go through when they first appeared, whether the number is growing, whether anyone in the family has something similar, and whether you've had them treated elsewhere before. Two people with the same eye area and different answers here end up on different plans.
What checking and managing eye-area bumps actually involves
What checking and managing eye-area bumps actually involves
The first step is to stop treating them yourself. Opening them with a fingernail or a pin marks the thin skin around the eye easily, and it raises the risk of infection at the same time.
The second step is identifying the type. Milia often resolve once the surface is opened and the contents removed, and for widespread lesions topical retinoids are described as helpful. Syringomas involve the tissue itself, so the approach differs.
The third step is hearing the risks in advance. The research paper above notes that all therapies for syringoma carry the potential for scarring, pigmentary changes and tumour recurrence. The same paper reports treating 64 patients by inserting a needle electrode into each lesion and delivering high-frequency current, with no permanent side effects or recurrences afterwards. It's worth reading that alongside the limited number of cases.
The fourth step is deciding when you'd come back. If redness or a change in pigment lasts longer than expected at the treated site, or if something rises in the same spot again, raise it with the team who performed the procedure first.
A standard worth writing down today
A standard worth writing down today
The eye area is somewhere your hands go often, which also makes it somewhere a mishandled bump leaves a mark. So identification comes before method.
First, a bump that won't squeeze isn't asking you to press harder. Second, milia and syringomas start in different tissue, so their management and their likelihood of returning follow different paths. Third, when you can't tell which one you're looking at, decide alongside a board-certified dermatologist who has examined the area.
Writing that standard down makes the next consultation easier to steer. This is an area where sorting the type first holds steadier than picking a method first.
If this raised a question about your own skin
Ask a questionReferences
- a small cyst containing keratin*, usually appearing in multiples and particularly prominent on the eyelids and cheeks — DermNet NZ
- a benign adnexal tumour derived from the acrosyringium, commonly found in clusters on and around the eyelids — DermNet NZ
- the bulk of the abnormal tissue can extend as far down as the upper reticular dermis, making these tumours resistant to superficial surgical destruction — PubMed Central
Frequently asked questions
Q. Can't I just squeeze them like a pimple?
A. The skin around the eye is thin, so opening a bump by hand marks it easily. The New Zealand dermatology resource describes de-roofing milia with a sterile needle or blade and lifting the contents out. Start by sorting three things: ① when they first appeared, ② whether the number is growing, and ③ whether they've been treated before.
Q. Will they go away on their own if I wait?
A. That depends on the type. The same resource notes that milia may clear in a few weeks or persist for months or longer. Syringomas, though benign, aren't described as something that resolves by itself.
Q. Why did they come back after being removed once?
A. Depth is the likely reason. A research paper explains that syringoma tissue can extend as far down as the upper reticular dermis, making it resistant to superficial destruction. Treat only the surface and what's left can show again. Individual results vary, so please decide with a board-certified dermatologist.
Q. I'm worried about being left with a mark.
A. Hearing the risks first helps. The same paper notes that all therapies for syringoma carry the potential for scarring, pigmentary changes and recurrence. Pigment change is especially visible around the eye, so it's worth agreeing on a sun-protection plan for afterwards at the same time.
Treatment guide for this topic
Medical information notice
This article provides general medical information and does not replace an individual diagnosis or medical consultation. View our editorial policy

Jangju Kim Senior Director
JANGJU KIM
Dr. Jangju Kim is a clinic director at STON Clinic, LOTTE HOTEL in Myeongdong.
Career / Education
- 현) 스톤클리닉 명동 롯데호텔 원장
- 경희대학교 의과대학 졸업
Comments